secwatch / observer
8-K filed January 4, 2022, 6:59 PM ET ticker NUMD CIK 0001543637
leadership confidence high sentiment negative materiality 0.50

Nu-Med Plus announces resignation of three officers/directors; Dr. Morrison moves to advisory board

Nu-Med Plus, Inc.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

William Moon

Vice President of Technology and director
NUMD · Nu-Med Plus, Inc.
Effective
2021-12-31
Filed
January 4, 2022, 6:59 PM ET
On December 31, 2021, Thomas Tate resigned as Vice President of Scientific Development and a director; William Moon resigned as Vice President of Technology and a director; and Dr. Craig Morrison resigned as Vice President of Research and a director.
Role change

Dr. Craig Morrison

Medical Advisory Board
NUMD · Nu-Med Plus, Inc.
Effective
2021-12-31
Filed
January 4, 2022, 6:59 PM ET
Dr. Craig Morrison resigned as Vice President of Research and a director. Dr. Morrison is moving to a position on our Medical Advisory Board.
Departed

Thomas Tate

Vice President of Scientific Development and director
NUMD · Nu-Med Plus, Inc.
Effective
2021-12-31
Filed
January 4, 2022, 6:59 PM ET
On December 31, 2021, Thomas Tate resigned as Vice President of Scientific Development and a director; William Moon resigned as Vice President of Technology and a director; and Dr. Craig Morrison resigned as Vice President of Research and a director.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

William Moon resigned as Vice President of Technology and director at Nu-Med Plus, Inc..

Action
resigned
Role
Vice President of Technology and director
Exact text from the filing
On December 31, 2021, Thomas Tate resigned as Vice President of Scientific Development and a director; William Moon resigned as Vice President of Technology and a director; and Dr. Craig Morrison resigned as Vice President of Research and a director.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Craig Morrison departed as Medical Advisory Board at Nu-Med Plus, Inc..

Action
resigned and moved to Medical Advisory Board
Role
Medical Advisory Board
Exact text from the filing
Dr. Craig Morrison resigned as Vice President of Research and a director. Dr. Morrison is moving to a position on our Medical Advisory Board.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Thomas Tate resigned as Vice President of Scientific Development and director at Nu-Med Plus, Inc..

Action
resigned
Role
Vice President of Scientific Development and director
Exact text from the filing
On December 31, 2021, Thomas Tate resigned as Vice President of Scientific Development and a director; William Moon resigned as Vice President of Technology and a director; and Dr. Craig Morrison resigned as Vice President of Research and a director.
View on SEC.gov

Nu-Med Plus, Inc. filing history →

Source: SEC EDGAR
accession 0001548123-22-000001
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.